Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page
Petersburg City Public Schools Debuts New Playground at Pleasants Lane Elementary as Part of a Ribbons of Love Celebration

Petersburg City Public Schools Debuts New Playground at Pleasants Lane Elementary as Part of a Ribbons of Love Celebration

2021, Phlow™ in the News, Press Releases

PETERSBURG, Va.— Petersburg City Public Schools announced the opening of a new playground at Pleasants Lane Elementary School in Petersburg, Virginia today. The “Ribbons of Love” celebration led by Superintendent Dr. Maria Pitre-Martin offered all of the 572 students...

Statement of Phlow Corp. on the Introduction of the “PREPARE Act”

2021, Corporate Statements

RICHMOND, Va.– Today Phlow™ Corp. released the following statement on the introduction of H.R. 5388, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act of 2021 in the United States House of...

National Essential Medicine Shortage Awareness Day Highlights a Critical Public Health Issue that Demands America’s Attention

2021, Press Releases

RICHMOND, Va., September 8, 2021 – Phlow, a U.S.-based, essential medicines impact company, today announced its support of the first-ever National Essential Medicine Shortage Awareness Day. This observance was created to educate the public about the ongoing crisis of...

Observance Day Overview

2021, Other News

Phlow Corp. CEO Publishes Op-Ed in Harvard Business Review

2021, Phlow™ in the News

Source: Harvard Business Review Eric Edwards, M.D., Ph.D., co-founder, President, and CEO of Phlow, has published an op-ed titled “The U.S. Needs to Reimagine Its Pharma Supply Chain” in Harvard Business Review about essential medications currently in shortage. “When...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Achieves Completion of Full-Scale Demonstration of Succinylcholine Chloride Active Pharmaceutical Ingredient (API) Production at its U.S. Metric Ton Facility
  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies